THRD - Third Harmonic Bio, Inc.
5.14
-0.010 -0.195%
Share volume: 285,901
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$5.15
-0.01
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-15-2024 | 08-08-2024 | 11-07-2024 | 03-27-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 11.290 M | 14.070 M | 17.073 M | 16.439 M | |
| Selling general and admin | 5.064 M | 5.676 M | 5.730 M | 5.902 M | |
| Research and development | 6.226 M | 8.394 M | 11.343 M | 10.537 M | |
| Total expenses | 11.290 M | 14.070 M | 17.073 M | 16.439 M | |
| 24.62% | 21.34% | -3.71% | |||
| Operating income | -11.290 M | -14.070 M | -17.073 M | -16.439 M | |
| Ebit | -11.289 M | -14.071 M | -17.077 M | -16.439 M | |
| Pretax income | -7.856 M | -10.707 M | -13.799 M | -13.107 M | |
| 36.29% | 28.88% | -5.01% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -7.856 M | -10.707 M | -13.799 M | -13.107 M | |
| -36.29% | -28.88% | 5.01% |
